Headhunter's 8 Rules for Acing the Job Interview - July 12, 2012

Having trouble viewing this email? View in Browser.

Thursday, July 12, 2012  |   |   |   |  Pharmaceutical & Healthcare Marketing MBA Program for Executives The Executive programs in Pharmaceutical & Healthcare Marketing at Saint Joseph's University are ideal for working professionals in the pharma, biotech, medical device, diagnostics and healthcare sectors. Our Classroom model combines the convenience of Friday/Saturday classes with pre- and post-assignments. Our Online students complete a course each month and participate in 3-4 multi-day residencies. Perfect for those who travel, may be transferred/promoted, and who need access from anywhere across North America and beyond. Please click here for more information. Headhunter's 8 Rules for Acing the Job Interview By Skip Freeman, Headhunter" Hiring Secrets Each and every week of the year, my executive recruiting firm, The HTW (Hire to Win) Group, has candidates going in for face-to-face job interviews. The candidates we present, versus those who choose to do it alone, end up winning the job 70% of the time. What makes the difference? More... More Features • 5 Most-Overlooked Components of a Powerful Executive Resume More... • What NOT to Add in Your Executive Resume More... • 4 Key Things to Remember in Your First Job Interview More... • 6 Reasons to Be More Valuable to Employers More... • Avoid These 5 Common Phrases on Your Executive Resume More... More Career Features Post Master's Graduate Certificate in Sequence Analysis and Genomics This new certificate is targeted at scientists who already have grounding in biochemistry, molecular biology and cell biology and but need the bioinformatics skills to design experiments and analyze data. The program introduces students to the foundations of bioinformatics through the core bioinformatics courses and then the students take upper level courses that are required for understanding and performing sequence and genomic analysis. This program will be offered online and onsite. Please click here for more information. • Forest Laboratories, Inc. (FRX) Hires Search Firm to Hunt for New CEO More... • Gen9 Announces Appointment of Kevin Munnelly as President and CEO More... • Brian Klein to Join Stifel Nicolaus' Healthcare Equity Research Team More... • Lance Alstodt Joins Leerink Swann and Company More... • TREVENTIS Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimer's Disease Research, His Third Endowed Chair More... More Who's Who • Genetown (Lexington, Massachusetts) Shire Director, Franchise Operations Lead Responsible for directing the operational, planning, and decision-making processes of the Global Franchise Team (FT). Duties: Develop plans, options, and business cases for life cycle investments, i.e. lead cross-functional process (including FT members and function representatives) to define and assess options, and present recommendations to FT etc. • BioMidwest (Lansing, Michigan) Emergent BioSolutions Supervisor, Microbiology Duties: Oversee the daily activities of the Microbiology group within the QC Microbiology department. Coordinate testing activities and associated work schedules for all department shifts, including holidays and weekends. Assign and monitor the training of department personnel. Review and approve LIMS data etc. • Biotech Bay (San Carlos, California) Natera Research Associate Duties: Receive and process laboratory specimens following the standard methods and procedures with superb attention to detail. Track samples with use of LIMS, database queries, and advanced excel techniques; verify that correct specimens are being processed and analyzed. Maintain equipment and instruments in good operating condition, recognize any malfunctions and troubleshoot as needed etc. • Biotech Beach (San Diego, California) BP Biofuels Analytical Chemist - Spectroscopy Expert The successful candidate will contribute to a number of projects supporting optimization and commercialization of current lignocellulosic ethanol process and development of new biofuels technology platforms. • BioForest (Bothell, Washington) Seattle Genetics, Inc. Senior Scientist, Chemical Development Will be responsible for developing novel synthetic routes and chemical processes for anti-cancer drugs and proprietary drug linkers used for antibody conjugation. The ideal candidate should possess an in-depth knowledge of organic chemistry, reaction mechanisms, and should have experience in pharmaceutical process chemistry. Experience and expertise in peptide synthesis is desirable. Particular experience in executing chemical processes within GMP compliant facilities would be preferable. Test Your Resume: Resumeter is the only technology that helps you beat the computerized screening process. Try it here! • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! •  Chelsea Therapeutics, Inc. (CHTP) to Significantly Cut Jobs, CEO Resigns More... •  QLT Inc. (QLTI) Slashes Workforce by Two-thirds, CEO Quits After Shareholder Coup More... •  Cardiome Pharma Corp. (COM.TO) to Axe 85 Pct. of Jobs More... More Top Stories 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Career Change Resume Advice Thank You Notes Cover Letters Networking Your Job Offer Internships On the Job Resignation Interviews Self Assessment Job Industry Finding a Job Salary Diversity References Social Media   Job Seeker Login Most Recent Jobs Search Jobs Post Resume Career Fairs Career Resources Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace, Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace, Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. BioSpace Ranked Among WEDDLE'S Top 100 For 2011/12   • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.   If someone forwarded this news to you and you'd like to receive your own complimentary copy, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.  Subscribe to: Post Comments (Atom) Click and Post Blog Archive ▼  2012 (843) ►  August (101) ▼  July (89) FDA Rejects Regeneron's Arcalyst for Gout - July 3... Dendreon Cuts 600 Jobs in Cost-Saving Move - July ... JAX® In Vivo Pharmacology Services Otologics Files for Ch. 11; Teleflex to Bring 225 ... Dendreon to Slash 600 Jobs - July 31, 2012 Progenics, Salix Hammered on Relistor Rejection - ... Roche to Create Jobs in CN Amid U.S. Site Closures... Roper Shells Out $1.4B Cash for Sunquest - July 30... Roche to Create 1,000 Jobs in CN; Progenics, Salix... FDA Approves Amarin's Heart Pill - July 27, 2012 Will Biogen Fall for Elan's Buyout Bait? - July 27... Cook Medical Shelves Midwest Expansion Plans - Jul... ALZ's Blow Makes Elan Takeover Bait to Biogen - Ju... Sanofi Edges Closer to World's First Dengue Vaccin... Genzyme's R&D Culture Pushes Sanofi CEO Into Actio... Gain detailed device business intelligence with ‘T... Bayer Rumored to Unload Diabetes Device Unit - Jul... Biotech Investor NEA Raises $2.6B; bluebird Snags ... 6 Ways to Save Biotech -- July 25, 2012 PFE, J&J ALZ's Drug Fails Its First Big Trial - Ju... Merck Lands Chimerix's HIV Program in $168.5M Deal... Streamline Drug Discovery Histogenics Scores $49M Series A Financing - July ... Merck Inks $168.5M HIV Pact; Pfizer-J&J ALZ's Drug... Bayer, Onyx's CA Drug Fails Late-stage Trial - Jul... Amarin's Website Blunder Pushes Shares Higher - Ju... Fresenius Pays $1.1B for Fenwal; UW Snags $65M Med... Fresenius Pays $1.1B for Fenwal; Web Goof Gives Am... Onyx Soars as FDA OKs Multiple Myeloma Drug - July... FDA Whistleblower Has Stirred the Pot Before - Ju... Another Day, Another Recall for J&J - July 20, 2012 Roche Moves Secret Heart Drug to Ph3; BMY Drug Fai... Could Breaking Up Be J&J's Salvation? - July 19, 2012 EMA Accepts Pfizer's BZA/CE MAA for Review - July... Roche Wins FDA Nod for Insulin Pump System - July ... Is Breaking Up J&J the Right Thing to Do? - July ... FDA Approves Vivus' Weight-loss Pill Qsymia - Jul... J&J Unit Slashes 200 Jobs - July 18, 2012 Tecomet Pays $45M Cash for Teleflex's OEM Biz - Ju... Vivus Soars as FDA OKs Diet Drug; J&J Cuts 200 Job... Vivus, Orexigen Stock Volatile Awaiting FDA Verdic... MedImmune Slashes 200 Jobs in R&D Restructuring - ... Register for a JAX webinar: Modeling Human Maligna... Steris Snags US Endoscopy for $270M Cash - July 17... MedImmune Chops 200 Jobs; 2 Pharma Cos. Set to Soa... FDA OKs Gilead's Truvada for HIV Prev.; Hospira Re... GSK Finally Bags HGSI in $2.8B Deal - July 16, 2012 Thermo to Pay $925M Cash for One Lambda; KCI Lays ... GSK Clinches $2.8B HGSI Takeover; FDA Spied on Its... Purdue's Redesigned OxyContin Drives Heroin Use - ... AZN's R&D Shake-up is Already Bearing Fruit - Jul... Hologic to Pay Gen-Probe CEO $6.9M to Stay On - J... AZN Claims Pay Off in Neurosci. Shake-Up; Genmab, ... Merck Stops Bone Drug Trial on Positive Results - ... Actelion to Cut 135 Jobs in R&D Revamp - July 12, ... Alere Recalls 897,000 Heart Attack, Drug Test Kits... Actelion to Slash R&D Jobs and Refocus Research - ... Headhunter's 8 Rules for Acing the Job Interview -... Your Healthy News FDA Suspends Ipsen's Ph3 Hemophilia Drug Study - J... Forest Hires Search Firm to Hunt for New CEO - Jul... Luminex Pays $50M Cash for GenturaDx; Neuravi to C... FDA Halts Ipsen's Hemophilia Trial; EU VC Nabs $15... Revitalize Your Potential with SJU Chelsea CEO Exits, Cuts Jobs to Save Northera - Ju... Merck Accused of Lying About Vaccine Effectiveness... Avinger Nabs $33M; Mako Sinks After Cutting Device... Chelsea Goes on Survival Mode; QLT Axes 146 Staffe... Bayer, J&J's Xarelto Wins FDA Priority Review - Ju... Savient to Slash Jobs, Taps New CEO - July 9, 2012 Stryker Recalls Hip Products Over Corrosion Risks ... Cardiome to Axe 85 Pct. of Jobs; Biolex Files for ... Pfizer Yanks Breast, Colon Claims From Centrum Vit... Forest Slammed With $100M Gender Bias Suit - July ... Bausch & Lomb Eyes 2012 IPO; FDA OKs Roche's CMV T... Forest Hit with $100M Sex Descrimination Suit - Ju... Up to 2,000 Jobs to Go at Sanofi - July 5, 2012 Merck Drug Fails in Stomach CA Trial - July 5, 2012 MDxHealth, Merck Ink Diagnostic Pact; Owen Mumford... Sanofi to Slash Up to 2,000 Jobs - July 5, 2012 How Genentech Kicks Roche's Butt in R&D Showdown -... Osiris Fibs About Clinical Trial Results - July 3,... CareFusion Recalls Infant Breathing Product - July... GlobeImmune Files for $69M IPO; Osiris Fibs About ... Unreserved Bio-Laboratory Auction Astra, Bristol Shell Out $7B for Amylin - July 2, ... Positive Data for GSK, Theravance's Combo Lung Dru... Medtronic CEO Gets $25M; Sorin Makes $14M Buy - Ju... Astra, Bristol Join Forces in $7B Deal for Amylin ... ►  June (96) ►  May (102) ►  April (96) ►  March (124) ►  February (119) ►  January (116) ►  2011 (773) ►  December (106) ►  November (113) ►  October (116) ►  September (123) ►  August (129) ►  July (111) ►  June (75)